Despite economic slowdown, the war at its borders, internal tensions and uncertainties, Romania corporate system reported overall net profit of almost RON1,000 billion (EUR200 billion) in the four post-pandemic years (2021-2024).
Drug maker Zentiva, with two plants in Bucharest, carried our RON56 million investment in 2024 (over EUR10 million) and investment plans continue. At present, the company is looking to boost production capacity and reduce environmental impacts.